- Home
- CMPX vs NNY Comparison
CMPX vs NNY Comparison
Compare CMPX & NNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- NNY
- Stock Information
- Founded
- CMPX 2014
- NNY 1987
- Country
- CMPX United States
- NNY United States
- Employees
- CMPX N/A
- NNY N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- NNY Investment Managers
- Sector
- CMPX Health Care
- NNY Finance
- Exchange
- CMPX Nasdaq
- NNY Nasdaq
- Market Cap
- CMPX 214.6M
- NNY 157.9M
- IPO Year
- CMPX N/A
- NNY N/A
- Fundamental
- Price
- CMPX $2.00
- NNY $8.07
- Analyst Decision
- CMPX Strong Buy
- NNY
- Analyst Count
- CMPX 4
- NNY 0
- Target Price
- CMPX $13.75
- NNY N/A
- AVG Volume (30 Days)
- CMPX 1.8M
- NNY 50.9K
- Earning Date
- CMPX 11-12-2024
- NNY 01-01-0001
- Dividend Yield
- CMPX N/A
- NNY 4.04%
- EPS Growth
- CMPX N/A
- NNY N/A
- EPS
- CMPX N/A
- NNY N/A
- Revenue
- CMPX $850,000.00
- NNY N/A
- Revenue This Year
- CMPX N/A
- NNY N/A
- Revenue Next Year
- CMPX $613.39
- NNY N/A
- P/E Ratio
- CMPX N/A
- NNY N/A
- Revenue Growth
- CMPX N/A
- NNY N/A
- 52 Week Low
- CMPX $0.77
- NNY $7.58
- 52 Week High
- CMPX $2.68
- NNY $8.87
- Technical
- Relative Strength Index (RSI)
- CMPX 65.48
- NNY 40.96
- Support Level
- CMPX $1.43
- NNY $8.05
- Resistance Level
- CMPX $2.68
- NNY $8.13
- Average True Range (ATR)
- CMPX 0.24
- NNY 0.08
- MACD
- CMPX 0.06
- NNY 0.01
- Stochastic Oscillator
- CMPX 46.87
- NNY 36.67
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About NNY Nuveen New York Municipal Value Fund
Nuveen New York Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from both regular federal and New York state income taxes, by investing primarily in a portfolio of municipal obligations issued by state and local government authorities within the state of New York or certain U.S. territories.